Greif, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Buy

54

GEF
Greif, Inc.

Last Price:

$69.82

Seasonality Move:

-1.22%

Sell

39

NKTR
Nektar Therapeutics

Last Price:

$53.62

Seasonality Move:

11.58%

Buy

54

Greif, Inc. (GEF) is a Buy

Is Greif, Inc. a Buy, Sell or Hold?

The current Greif, Inc. [GEF] share price is $68.40. The Score for GEF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
GEF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

39

Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GEF Stock Price Chart

What is Greif, Inc.'s stock price today?

The Greif, Inc. share price today is $68.40

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GEF is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

The Nektar Therapeutics share price today is $54.70

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

GEF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.89	Buy
Relative Strength Index (14 RSI):	72.65	Buy
Chaikin Money Flow:	67806	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(60.56 - 66.28)	Buy
Bollinger Bands (100):	(58.89 - 65.71)	Buy

NKTR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.71	Sell
Relative Strength Index (14 RSI):	45.77	Sell
Chaikin Money Flow:	141668	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(54.71 - 61.07)	Sell
Bollinger Bands (100):	(32.74 - 62.56)	Buy

GEF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	66.28	Buy
20-day SMA:	64.32	Buy
50-day SMA:	61.09	Buy
200-day SMA:	60.3	Buy
8-day EMA:	66.51	Buy
20-day EMA:	64.6	Buy
50-day EMA:	62.6	Buy
200-day EMA:	61.66	Buy

NKTR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	56.42	Sell
20-day SMA:	58.12	Sell
50-day SMA:	58.41	Sell
200-day SMA:	30.65	Buy
8-day EMA:	56.16	Sell
20-day EMA:	57.43	Sell
50-day EMA:	55.78	Sell
200-day EMA:	37.86	Buy

Greif, Inc. Earnings Growth & GEF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $1.18 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Greif, Inc. Technical Analysis

	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12
	Dec
	01	02	03	04	05	08	09	10	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12
	Dec
	01	02	03	04	05	08	09	10	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):